People Injured or Bereaved by Covid Vaccines ‘Speak in Code Online Over Censorship Fears’
November 9, 2023
The Mysterious Case of the Disappearing EU Pharma Report
November 9, 2023

Bayer Ordered to Pay $332 Million in Roundup Cancer Trial


A California jury has found Bayer liable in a case brought by a man who says his cancer resulted from exposure to the weedkiller Roundup, and ordered the firm to pay $332 million in damages.


The third loss in a matter of weeks for Bayer in Roundup-related cases, the verdict in this trial awarded the claimant $7 million in compensatory damages and $325 million in punitive damages. Roundup lawsuits have plagued Bayer since it acquired the brand as part of its disastrous $63 billion purchase of agrochemicals firm Monsanto in 2018. Bayer settled most of the claims in 2020 for around $10.9 billion, but still faces almost 40,000 additional cases.

In this situation, with Bayer’s stock price having nosedived by more than 50 percent since 2015, many of the firm’s investors are pushing for Monsanto to be cut off and sold. The World Health Organization’s International Agency for Research on Cancer (IARC) acknowledged in 2015 that glyphosate was “probably carcinogenic to humans,” and studies have since provided “compelling evidence” that the chemical increases the risk of developing non-Hodgkin lymphoma.

To read about rumors that the corporate marriage between Bayer and Monsanto may be heading for divorce, see this article on our website.